1. Developing, Purchasing, Implementing and Monitoring AI Tools in Radiology: Practical Considerations. A Multi-Society Statement From the ACR, CAR, ESR, RANZCR & RSNA.
- Author
-
Brady AP, Allen B, Chong J, Kotter E, Kottler N, Mongan J, Oakden-Rayner L, Dos Santos DP, Tang A, Wald C, and Slavotinek J
- Subjects
- Humans, Canada, Europe, New Zealand, United States, Australia, Artificial Intelligence, Radiology, Societies, Medical
- Abstract
Artificial Intelligence (AI) carries the potential for unprecedented disruption in radiology, with possible positive and negative consequences. The integration of AI in radiology holds the potential to revolutionize healthcare practices by advancing diagnosis, quantification, and management of multiple medical conditions. Nevertheless, the ever‑growing availability of AI tools in radiology highlights an increasing need to critically evaluate claims for its utility and to differentiate safe product offerings from potentially harmful, or fundamentally unhelpful ones. This multi‑society paper, presenting the views of Radiology Societies in the USA, Canada, Europe, Australia, and New Zealand, defines the potential practical problems and ethical issues surrounding the incorporation of AI into radiological practice. In addition to delineating the main points of concern that developers, regulators, and purchasers of AI tools should consider prior to their introduction into clinical practice, this statement also suggests methods to monitor their stability and safety in clinical use, and their suitability for possible autonomous function. This statement is intended to serve as a useful summary of the practical issues which should be considered by all parties involved in the development of radiology AI resources, and their implementation as clinical tools., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: APB: member of the Insights into Imaging Scientific Editorial Board. He has not taken part in the review or selection process of this article. BA: No competing interests. JC: No competing interests. EK: Shareholder Gleamer, Paris and Contextflow, Vienna. NK: Consultant for ES3 (aerospace company), consultant for Synapsica Healthcare, partner (equity owner) at Radiology Partners (RP), sole or partial owner of several radiology practices managed by RP. RP has a minority interest in AIDOC. RP has an indirect minority interest in Rad AI. Associate Fellow Stanford AIMI Center. Hold several volunteer positions at RSNA, ACR, SIIM and RADequal. JM: Consultant, Microsoft (Nuance), Research funding, royalties, GE, Research funding, Siemens, Spouse employment, shareholder Annexon Biosciences, Spouse employment Bristol Meyers Squibb. LOR: No competing interests. DPDS: member of the Insights into Imaging Scientific Editorial Board. He has not taken part in the review or selection process of this article. AT: No competing interests. CW: Chair, Commission on Informatics and Member, Board of Chancellors, American College of Radiology. Advisor: Notable Systems, and RadPair. JS: No competing interests.
- Published
- 2024
- Full Text
- View/download PDF